Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 3/20 | 0.73 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.73 |
| ▸ | MEN1 | O00255 | 2/20 | 0.61 |
| ▸ | POLB | P06746 | 2/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.61 |
| ▸ | ALPL | P05186 | 1/20 | 0.61 |
| ▸ | ALPI | P09923 | 1/20 | 0.61 |
| ▸ | ALPG | P10696 | 1/20 | 0.61 |
| ▸ | ATM | Q13315 | 1/20 | 0.60 |
| ▸ | PLEC | Q15149 | 1/20 | 0.60 |
| ▸ | CA9 | Q16790 | 14/20 | 0.59 |
| ▸ | CA1 | P00915 | 12/20 | 0.59 |
| ▸ | CA2 | P00918 | 12/20 | 0.59 |
| ▸ | CA12 | O43570 | 4/20 | 0.56 |
| ▸ | DNASE1L3 | Q13609 | 1/20 | 0.55 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.55 |
| ▸ | ESR1 | P03372 | 1/20 | 0.54 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.53 |
| ▸ | CA7 | P43166 | 2/20 | 0.52 |
| ▸ | ALB | P02768 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12061907 | 0.93 | USP2 (0.66) | USP2L3MBTL1MEN1POLBKMT2A | |
| SCHEMBL1437042 | 0.92 | USP2 (0.78) | USP2L3MBTL1MEN1POLBKMT2A | |
| SCHEMBL10142506 | 0.91 | USP2 (0.67) | USP2L3MBTL1MEN1POLBKMT2A | |
| SCHEMBL12463125 | 0.89 | USP2 (0.77) | USP2L3MBTL1MEN1POLBKMT2A | |
| SCHEMBL19423916 | 0.89 | USP2 (0.73) | USP2L3MBTL1MEN1POLBKMT2A | |
| SCHEMBL19449068 | 0.89 | USP2 (0.69) | USP2L3MBTL1MEN1POLBKMT2A | |
| SCHEMBL10138306 | 0.89 | USP2 (0.69) | USP2L3MBTL1MEN1POLBKMT2A | |
| SCHEMBL19543669 | 0.89 | USP2 (0.69) | USP2L3MBTL1MEN1POLBKMT2A | |
| SCHEMBL14563221 | 0.89 | USP2 (0.69) | USP2L3MBTL1MEN1POLBKMT2A | |
| SCHEMBL20990646 | 0.87 | USP2 (0.67) | USP2L3MBTL1MEN1POLBKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3294811-B1 | ULTRA BRIGHT DIMERIC OR POLYMERIC DYES | SONY GROUP CORP (JP) | 2024-02-28 | — | — | EP | disclosed |
| EP-3737418-B1 | POLYMERS WITH RIGID SPACING GROUPS COMPRISING BIOLOGICALLY ACTIVE COMPOUNDS | SONY GROUP CORP (JP) | 2024-02-28 | — | — | EP | disclosed |
| EP-3455299-B1 | COMPOSITIONS COMPRISING A POLYMERIC DYE AND A CYCLODEXTRIN AND USES THEREOF | SONY GROUP CORP (JP) | 2024-01-17 | — | — | EP | disclosed |
| WO-2023242661-A2 | POLYMERIC TANDEM DYES WITH SPACING LINKER GROUPS | Sony Group Corporation (JP) | 2023-12-21 | — | — | WO | disclosed |
| WO-2023242662-A2 | POLYMERIC TANDEM DYES WITH SPACING LINKER GROUPS | Sony Group Corporation (JP) | 2023-12-21 | — | — | WO | disclosed |
| EP-4234689-A2 | SPLIT INTEINS WITH EXCEPTIONAL SPLICING ACTIVITY | The Trustees of Princeton University (US) | 2023-08-30 | — | — | EP | disclosed |
| US-20230129481-A1 | ULTRA BRIGHT DIMERIC OR POLYMERIC DYES WITH SPACING LINKER GROUPS | Sony Group Corporation (JP) | 2023-04-27 | — | — | US | disclosed |
| EP-3408292-B1 | SPLIT INTEINS WITH EXCEPTIONAL SPLICING ACTIVITY | UNIV PRINCETON (US) | 2023-04-26 | — | — | EP | disclosed |
| EP-4137818-A1 | USE OF DIVALENT METALS FOR ENHANCEMENT OF FLUORESCENT SIGNALS | Sony Group Corporation (JP) | 2023-02-22 | — | — | EP | disclosed |
| US-20220220314-A1 | POLYMERIC DYES WITH LINKER GROUPS COMPRISING DEOXYRIBOSE | Sony Group Corporation (JP) | 2022-07-14 | — | — | US | disclosed |
| US-8835480-B2 | Inhibitors for steroid response elements and related methods | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2014-09-16 | — | — | US | disclosed |
| US-20120058932-A1 | ACTIVE INGREDIENT-PEPTIDE CONSTRUCT FOR EXTRACELLULAR CONCENTRATION | MAX PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN E.V. (DE) | 2012-03-08 | — | — | US | disclosed |
| US-7923433-B2 | Activity-based probes and methods of their preparation and use | ACTIVX BIOSCIENCES, INC. (US) | 2011-04-12 | — | — | US | disclosed |
| US-7923433-B2 | Activity-based probes and methods of their preparation and use | ACTIVX BIOSCIENCES, INC. (US) | 2011-04-12 | — | — | US | disclosed |
| EP-2230314-A1 | Method of sensing an analyte | The Board of Regents,The University of Texas System (US) | 2010-09-22 | — | — | EP | disclosed |
| US-7365178-B2 | Acyl-nucleotide probes and methods of their synthesis and use in proteomic analysis | ACTIVX BIOSCIENCES, INC. (US) | 2008-04-29 | — | — | US | disclosed |
| US-7365178-B2 | Acyl-nucleotide probes and methods of their synthesis and use in proteomic analysis | ACTIVX BIOSCIENCES, INC. (US) | 2008-04-29 | — | — | US | disclosed |
| US-7256019-B2 | Terminal phosphate blocked nucleoside polyphosphates | GE HEALTHCARE BIO-SCIENCES CORP. (US) | 2007-08-14 | — | — | US | disclosed |
| US-20070141624-A1 | ACTIVITY-BASED PROBES AND METHODS OF THEIR PREPARATION ANS USE | ACTIVX BIOSCIENCES, INC. | 2007-06-21 | — | — | US | disclosed |
| US-20070141624-A1 | ACTIVITY-BASED PROBES AND METHODS OF THEIR PREPARATION ANS USE | ACTIVX BIOSCIENCES, INC. | 2007-06-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070141624-A1 | ACTIVITY-BASED PROBES AND METHODS OF THEIR PREPARATION ANS USE | DNPEP, CTRL, ARSA | USP2 157/4885L3MBTL1 2196/4885MEN1 4670/4885 |
| US-20220220314-A1 | POLYMERIC DYES WITH LINKER GROUPS COMPRISING DEOXYRIBOSE | H1-0, POLM, H1-2 | USP2 3575/4885L3MBTL1 7/4885MEN1 787/4885 |
| US-20230129481-A1 | ULTRA BRIGHT DIMERIC OR POLYMERIC DYES WITH SPACING LINKER GROUPS | IK, MTCL3, RRM1 | USP2 699/4885L3MBTL1 27/4885MEN1 1209/4885 |
| US-20120058932-A1 | ACTIVE INGREDIENT-PEPTIDE CONSTRUCT FOR EXTRACELLULAR CONCENTRATION | VIP, FIBP, MMP7 | USP2 4261/4885L3MBTL1 4427/4885MEN1 314/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.